Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Laura Martin De La Fuente"'
Autor:
Maria Bååth, Sofia Westbom-Fremer, Laura Martin de la Fuente, Anna Ebbesson, Juliette Davis, Susanne Malander, Anna Måsbäck, Päivi Kannisto, Ingrid Hedenfalk
Publikováno v:
Molecular & Cellular Oncology, Vol 7, Iss 6 (2020)
The transcription factor SOX2 is a well-established and important stem cell marker. Its role in cancer biology remains unclear, but it has been proposed to also be a marker of cancer stem cells. We investigated the role of SOX2 protein expression in
Externí odkaz:
https://doaj.org/article/6bd8032c7fe94d93b758c4fa7e5ea4fa
Autor:
Josefin Fernebro, Sara Corvigno, Arthur Mezheieusky, Josefin Severin Karlsson, Laura Martin De La Fuente, Sofia M Westbom-Fremer, Joseph Carlson, Paivi M Kannisto, Ingrid M Hedenfalk, Susanne M Malander, Arne Östman, Hanna Dahlstrand
Publikováno v:
Translational research/biomarkers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::267a80954ca0dcea8f8be40850874b86
https://doi.org/10.1136/ijgc-2022-esgo.880
https://doi.org/10.1136/ijgc-2022-esgo.880
Autor:
Arne Östman, Joseph W. Carlson, Artur Mezheyeuski, Charlotte Rolny, Susanne Malander, Sara Corvigno, Sofia Westbom-Fremer, Hanna Dahlstrand, Päivi Kannisto, Josefin Fernebro, Ingrid Hedenfalk, Laura Martin de la Fuente, Elisabeth Åvall-Lundqvist
Publikováno v:
Gynecologic Oncology. 159:860-868
Objective Pre-clinical studies have identified marker- and tumor compartment-defined functionally distinct macrophage subsets. Our study analyzes marker-defined macrophage subsets in different tumor compartments of high-grade serous ovarian cancer (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f819778d31f7fa9536af04caa9255ab6
https://doi.org/10.1016/j.ygyno.2020.09.041
https://doi.org/10.1016/j.ygyno.2020.09.041
Autor:
Ingrid Hedenfalk, Nicolai Skovbjerg Arildsen, Anna Måsbäck, Päivi Kannisto, Susanne Malander, Ola Forslund, Laura Martin de la Fuente
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports
Scientific Reports
High-grade serous ovarian cancer (HGSOC) is the most common subtype of epithelial ovarian cancer and early detection is challenging. TP53 mutations are a hallmark of HGSOC and detection of these mutations in liquid-based Pap samples could provide a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::296752e4b83be3bba969e7baebebc0ec
http://link.springer.com/article/10.1038/s41598-019-51697-6
http://link.springer.com/article/10.1038/s41598-019-51697-6
Autor:
Laura Martin de la Fuente, Sofia Westbom-Fremer, Susanne Malander, Linda Werner Hartman, Ingrid Hedenfalk, Anna Måsbäck, Päivi Kannisto, Nicolai Skovbjerg Arildsen
Publikováno v:
Virchows Archiv
The response rate to checkpoint inhibitors for women with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum (HGSC) is modest, and development of predictive biomarkers is needed. The main focus has been on tumor cell PD-L1 expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c2eeb6ba47c937d855c7317c3b4f171
https://pubmed.ncbi.nlm.nih.gov/31980961
https://pubmed.ncbi.nlm.nih.gov/31980961
Autor:
Håkan Olsson, Timothy Clough, Ruth Hüttenhain, Meena Choi, Olga Vitek, Ruedi Aebersold, Daniela M. Dinulescu, Viola Heinzelmann-Schwarz, Peter J. Wild, Laura Martin de la Fuente, Ching-Yun Veavi Chang, Kathrin Oehl, Susanne Malander, Emma Niméus, Silvia Surinova, Anne-Kathrin Zimmermann
Publikováno v:
Mol Cell Proteomics
Protein biomarkers for epithelial ovarian cancer are critical for the early detection of the cancer to improve patient prognosis and for the clinical management of the disease to monitor treatment response and to detect recurrences. Unfortunately, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2975e7a2da1b7aef258c79ffd99d731
https://europepmc.org/articles/PMC6731088/
https://europepmc.org/articles/PMC6731088/
Autor:
Linda Werner Hartman, Ingrid Hedenfalk, Jenny-Maria Jönsson, Susanne Malander, Mef Nilbert, Anna Måsbäck, Laura Martin de la Fuente, Anna Ebbesson
Publikováno v:
International Journal of Gynecological Pathology
Supplemental Digital Content is available in the text.
The tight junction protein claudin-4 has been reported to be overexpressed in advanced ovarian cancer. We investigated the prognostic significance of claudin-4 overexpression and whether cla
The tight junction protein claudin-4 has been reported to be overexpressed in advanced ovarian cancer. We investigated the prognostic significance of claudin-4 overexpression and whether cla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e2be0b46ab623d3fa761b4f7bcc64e
https://pubmed.ncbi.nlm.nih.gov/29750704
https://pubmed.ncbi.nlm.nih.gov/29750704
Autor:
Laura Martin de la Fuente, Minerva Li, Anna Måsbäck, Susanne Malander, Päivi Kannisto, Ingrid Hedenfalk
Publikováno v:
Lund University
BackgroundThe detection of ovarian carcinoma-derived somatic mutations in cervical samples and uterine lavages in several studies since 2013, has brought hope for the development of new biomarkers for early detection. High-grade serous ovarian carcin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0092bd50f3cf408809901041eef8042c
https://portal.research.lu.se/en/publications/f7e516af-c70d-47c2-b7ed-f0349f73d82f
https://portal.research.lu.se/en/publications/f7e516af-c70d-47c2-b7ed-f0349f73d82f